Literature DB >> 1115774

Evidence that the major cell suface glycoprotein of the TA3-Ha carcinoma contains the Vicia graminea receptor sites.

J F Codington, A G Cooper, M C Brown, R W Jeanloz.   

Abstract

The Vicia graminea lectin receptor of the nonstrain-specific TA3-Ha mammary carcinoma ascites cell of the strain A mouse was shown to be predominantly or exclusively on a large mucin-type surface glycoprotein. TA3-Ha cells adsorbed the lectin in amounts equivalent to 5-9 mg of this glycoprotein/10-9 cells, which was 100-400 times greater than by the strain-specific TA3-St cell, employed as a control. Release of sialic acid by incubation with neuraminidase increased the adsorptivity of the TA3-Ha cell three to fourfold and of the TA3-St cell six- to ten fold. Proteolysis of TA3-Ha cells released into the supernatant solutions approximately the same amount of inhibitory activity, equivalent to approximately 5 mg of the glycoprotein and only 10 per cent of the original adsorptivity remained on the cells. By contrast, TA3-St cells released no detectable inhibitory activity into the medium when subjected to similar proteolysis, even after neuraminidase treatment. Upon fractionation of released material on gel columns, high-molecular weight material and activity were found in the same fractions, but purified samples differed significantly in specific activity and carbohydrate composition. Heterogeneity in the carbohydrate moieties of the macromolecules was further demonstrated by incubation of these samples with neuraminidase, which enhanced their inhibitory activities from two- to tenfold.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1115774     DOI: 10.1021/bi00675a033

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Location of an epitopic site on epiglycanin by molecular immunoelectron microscopy.

Authors:  J K Wold; H S Slayter; J F Codington; R W Jeanloz
Journal:  Biochem J       Date:  1985-04-01       Impact factor: 3.857

2.  Distribution of receptor sites on large glycoprotein molecules by electron microscopy. Application to epiglycanin.

Authors:  H S Slayter; J F Codington
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

3.  Biosynthesis and shedding of epiglycanin: a mucin-type glycoprotein of the mouse TA3Ha mammary carcinoma cell.

Authors:  T Thingstad; H L Vos; J Hilkens
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

4.  In vivo localization of radioiodinated peanut lectin in a murine TA3/Ha mammary carcinoma model.

Authors:  A Shysh; S M Eu; A A Noujaim; M R Suresh; B M Longenecker
Journal:  Eur J Nucl Med       Date:  1985

5.  Structural and functional aspects of tumor cell sialomucins.

Authors:  K L Carraway; J Spielman
Journal:  Mol Cell Biochem       Date:  1986 Nov-Dec       Impact factor: 3.396

6.  Ultrastructural and histochemical differences in cell surface properties of strain-specific and nonstrain-specific TA3 adenocarcinoma cells.

Authors:  S C Miller; E D Hay; J F Codington
Journal:  J Cell Biol       Date:  1977-03       Impact factor: 10.539

7.  The mucin epiglycanin on TA3/Ha carcinoma cells prevents alpha 6 beta 4-mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction.

Authors:  H Kemperman; Y Wijnands; J Wesseling; C M Niessen; A Sonnenberg; E Roos
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.